9 Sep 2008 07:00
Abcam plc | |||
Consolidated Income Statement | |||
For the year ended 30 June 2008 | |||
Year ended | Year ended | ||
Notes | 30 June 2008 | 30 June 2007 | |
Restated* | |||
£000 | £000 | ||
Revenue | 5 | 36,694 | 24,519 |
Cost of sales | (14,389) | (10,020) | |
|
| ||
Gross profit | 22,305 | 14,499 | |
Administration and management expenses | (12,344) | (7,590) | |
excluding share based compensation charge |
|
| |
Share based compensation charge | (173) | (142) | |
Total management and administration expenses | (12,517) | (7,732) | |
Research and development expenses | (2,398) | (1,709) | |
excluding share based compensation charge |
|
| |
Share based compensation charge | (19) | (20) | |
Total research and development expenses | (2,417) | (1,729) | |
|
| ||
OPERATING PROFIT | 7,371 | 5,038 | |
Investment revenue | 5 | 581 | 495 |
|
| ||
PROFIT BEFORE TAXATION | 7,952 | 5,533 | |
Tax | 11 | (2,062) | (1,472) |
|
| ||
PROFIT FOR THE PERIOD FROM CONTINUING | 6,29 | 5,890 | 4,061 |
OPERATIONS | |||
Earnings per share | |||
from continuing operations - pence | |||
Basic | 13 | 16.88 | 11.74 |
Diluted | 13 | 16.56 | 11.43 |
*Restated to reflect the adoption of IFRS as per note 30. | |||
All profit is attributable to equity holders of the parent. |
Abcam plc | |||||||
Consolidated statement of recognised income and expense | |||||||
For the year ended 30 June 2008 | |||||||
Year ended | Year ended | ||||||
30 June 2008 | 30 June 2007 | ||||||
£000 | £000 | ||||||
(Losses)/gains on cash flow hedges | (168) | 168 | |||||
Exchange differences on translation of foreign operations | 3 | (28) | |||||
Deferred tax on outstanding share options | 502 | (30) | |||||
Net income recognised directly in equity | 337 | 110 | |||||
Profit for the year | 5,890 | 4,061 | |||||
Total recognised income and expense for the year | 6,227 | 4,171 | |||||
Abcam plc | ||||
Consolidated Balance Sheet | ||||
At 30 June 2008 | ||||
Notes | 30 June 2008 | 30 June 2007 | ||
Restated* | ||||
£000 | £000 | |||
Non-current assets | ||||
Intangible assets | 14 | 994 | 1,691 | |
Property, plant and equipment | 15 | 4,204 | 2,832 | |
5,198 | 4,523 | |||
Current assets | ||||
Inventories | 17 | 4,506 | 3,102 | |
Trade and other receivables | 18 | 4,860 | 4,327 | |
Cash and cash equivalents | 18 | 13,473 | 10,709 | |
Short term deposits | 18 | 1,020 | - | |
Derivative financial instruments | 19 | - | 168 | |
23,859 | 18,306 | |||
Total Assets | 29,057 | 22,829 | ||
Current Liabilities | ||||
Trade and other payables | 21 | (4,073) | (3,045) | |
Current tax liabilities | 21 | (382) | (248) | |
Provisions | 22 | (96) | (75) | |
Derivative financial instruments | 19 | (197) | - | |
(4,748) | (3,368) | |||
Net current assets | 19,111 | 14,938 | ||
Non-current liabilities | ||||
Deferred tax liabilities | 20 | (78) | (188) | |
Deferred creditor | 21 | (109) | (386) | |
(187) | (574) | |||
Total liabilities | (4,935) | (3,942) | ||
Net assets | 24,122 | 18,887 | ||
Equity | ||||
Share capital | 23,29 | 351 | 346 | |
Share premium account | 24,29 | 10,871 | 10,619 | |
Share based compensation reserve | 29 | 483 | 251 | |
Deferred tax reserve | 29 | 758 | 256 | |
Translation reserve | 29 | (33) | (36) | |
Hedging reserve | 29 | - | 168 | |
Retained earnings | 29 | 11,692 | 7,283 | |
Equity attributable to equity holders of the parent. | 24,122 | 18,887 | ||
*Restated to reflect the adoption of IFRS as per note 30. | ||||
The financial information was approved by the board of directors and | ||||
authorised for issue on 8 September 2008. | ||||
They were signed on its behalf by: | ||||
Jeff Iliffe | Director |
Abcam plc | ||||||||
Company Balance Sheet | ||||||||
At 30 June 2008 | ||||||||
Notes | 30 June 2008 | 30 June 2007 | ||||||
Restated* | ||||||||
£000 | £000 | |||||||
Non-current assets | ||||||||
Intangible assets | 14 | 994 | 1,691 | |||||
Property, plant and equipment | 15 | 3,976 | 2,459 | |||||
Investments | 16 | 45 | 16 | |||||
5,015 | 4,166 | |||||||
Current assets | ||||||||
Inventories | 17 | 4,501 | 3,089 | |||||
Trade and other receivables | 18 | 5,144 | 4,572 | |||||
Cash and cash equivalents | 18 | 11,918 | 10,055 | |||||
Short term deposits | 18 | 1,020 | - | |||||
Derivative financial instruments | 19 | - | 168 | |||||
22,583 | 17,884 | |||||||
Total Assets | 27,598 | 22,050 | ||||||
Current Liabilities | ||||||||
Trade and other payables | 21 | (3,623) | (2,864) | |||||
Current tax liabilities | 21 | (269) | (243) | |||||
Provisions | 22 | (96) | (75) | |||||
Derivative financial instruments | 19 | (197) | - | |||||
(4,185) | (3,182) | |||||||
Net current assets | 18,398 | 14,702 | ||||||
Non-current liabilities | ||||||||
Deferred tax liabilities | 20 | (178) | (188) | |||||
Deferred creditor | 21 | (109) | (386) | |||||
(287) | (574) | |||||||
Total liabilities | (4,472) | (3,756) | ||||||
Net assets | 23,126 | 18,294 | ||||||
Equity | ||||||||
Share capital | 23,29 | 351 | 346 | |||||
Share premium account | 24,29 | 10,871 | 10,619 | |||||
Share based compensation reserve | 29 | 444 | 251 | |||||
Deferred tax reserve | 29 | 758 | 256 | |||||
Hedging reserve | 29 | - | 168 | |||||
Retained earnings | 29 | 10,702 | 6,654 | |||||
23,126 | 18,294 | |||||||
*Restated to reflect the adoption of IFRS as per note 30. | ||||||||
The financial information was approved by the board of directors and | ||||||||
authorised for issue on 8 September 2008. | ||||||||
They were signed on its behalf by: | ||||||||
Jeff Iliffe | Director |
Abcam plc | |||||
Consolidated cash flow statement | |||||
For the year ended 30 June 2008 | |||||
Year ended | Year ended | ||||
Notes | 30 June 2008 | 30 June 2007 | |||
Restated* | |||||
£000 | £000 | ||||
Net cash from operating activities | 28 | 7,142 | 3,426 | ||
Investing activities | |||||
Interest received | 581 | 495 | |||
Proceeds on disposal of property, | |||||
plant and equipment | (1) | 2 | |||
Purchase of property, | |||||
plant and equipment | (2,445) | (2,316) | |||
Purchase of intangible | |||||
assets | (274) | (1,848) | |||
Net cash used in investing activities | (2,139) | (3,667) | |||
Financing activities | |||||
Dividends paid | (1,481) | (968) | |||
Proceeds on issue of shares | 257 | 47 | |||
Increase in short term deposits | (1,020) | - | |||
Net cash used in financing activities | (2,244) | (921) | |||
Net increase/(decrease) in cash and cash equivalents | 2,759 | (1,162) | |||
Cash and cash equivalents at beginning | |||||
of year | 10,709 | 11,884 | |||
Effect of foreign exchange rates | 5 | (13) | |||
Cash and cash equivalents at end of year | 13,473 | 10,709 | |||
*Restated to reflect the adoption of IFRS as per note 30. |
Abcam plc | |||||
Company cash flow statement | |||||
For the year ended 30 June 2008 | |||||
Year ended | Year ended | ||||
Notes | 30 June 2008 | 30 June 2007 | |||
Restated* | |||||
£000 | £000 | ||||
Net cash from operating activities | 28 | 5,858 | 2,736 | ||
Investing activities | |||||
Interest received | 561 | 504 | |||
Proceeds on disposal of property, | |||||
plant and equipment | 1 | 4 | |||
Purchases of property, | |||||
plant and equipment | (2,434) | (2,000) | |||
Purchases of intangible | |||||
assets | (251) | (1,848) | |||
Investment in subsidiary | (29) | - | |||
Dividends received | 401 | 269 | |||
Net cash used in investing activities | (1,751) | (3,071) | |||
Financing activities | |||||
Dividends paid | (1,481) | (968) | |||
Proceeds on issue of shares | 257 | 46 | |||
Increase in short term deposits | (1,020) | - | |||
Net cash used in financing activities | (2,244) | (922) | |||
Net increase/(decrease) in cash and cash equivalents | 1,863 | (1,257) | |||
Cash and cash equivalents at beginning | |||||
of year | 10,055 | 11,312 | |||
Cash and cash equivalents at end of year | 11,918 | 10,055 | |||
*Restated to reflect the adoption of IFRS as per note 30. |
Abcam plc | ||||||
Notes to the consolidated financial information | ||||||
For the year ended 30 June 2008 | ||||||
1.General information | ||||||
Abcam plc is a company incorporated in the England and Wales under the Companies Act 1985. | ||||||
The address of the registered office is 332 Cambridge Science Park, Milton Road, Cambridge, | ||||||
CB4 OFW United Kingdom. | ||||||
The Group's activities consist of the development, marketing and selling of antibodies and closely | ||||||
related products.The Group sells through the internet to customers in most countries of the | ||||||
world. The Group operates through its parent company Abcam plc and through its wholly owned | ||||||
subsidiaries Abcam Inc. and Abcam KK. | ||||||
This financial information is presented in pounds sterling because that is the currency of the | ||||||
Primary economic environment in which the Group operates. Foreign operations are included in | ||||||
accordance with the policies set out in note 2. | ||||||
2.Significant accounting policies | ||||||
Basis of Accounting | ||||||
The financial information set out in the announcement does not constitute the company's statutory accounts for the years ended 30 June | ||||||
2008 or 2007. The financial information for the year ended 30 June 2007 is derived from the statutory accounts for that year which have | ||||||
been delivered to the Registrar of Companies. The auditors reported on those accounts; their report was unqualified, did not draw attention | ||||||
to any matters by way of emphasis without qualifying their report and did not contain a statement under s237(2) or (3) Companies Act | ||||||
1985. | ||||||
Property, plant and equipment | ||||||
Property, plant and equipment is stated at cost less depreciation and any provision for | ||||||
impairment. Depreciation is provided at cost in equal instalments over the estimated lives | ||||||
of the fixed assets. | ||||||
The depreciation rates applied are shown below: | ||||||
Office equipment, fixtures and fittings | 20% per annum | |||||
Laboratory equipment | 20% per annum | |||||
Computer equipment | 33% per annum | |||||
Hybridomas | 33% per annum | |||||
Depreciation is accelerated if assets are deemed to have been impaired or there is a | ||||||
change in the residual economic life.The remaining useful lives of assets are re-assessed at each | ||||||
balance sheet date. | ||||||
Intangible assets | ||||||
Expenditure on research activities is recognised as an expense in the period | ||||||
in which it is incurred. | ||||||
Payments made to acquire distribution rights from third parties are capitalised and | ||||||
are amortised over the period of the agreement. | ||||||
These assets are amortised on a straight line basis over their estimated minimum useful lives of 3 years. | ||||||
Intangible assets are reviewed for impairment both annually and when there is an indication that | ||||||
an asset may be impaired when events or changes in circumstances indicate that the carrying | ||||||
value may not be recoverable. The assets' residual values, useful lives, and methods of | ||||||
valuation are reviewed and adjusted, if appropriate, at each financial year end. | ||||||
Investments | ||||||
Investments held as fixed assets are stated at cost less provision for any impairment in value. | ||||||
Inventories | ||||||
Inventories are stated at the lower of cost and net realisable value.Cost is calculated using the | ||||||
actual cost of the product when acquired or manufactured. | ||||||
The cost of Abcam own manufactured inventory includes material, direct labour and an attributable | ||||||
portion of production overheads based on normal levels of activity and is calculated using | ||||||
the standard cost method. | ||||||
Net realisable value is based on the estimated selling price less further costs expected | ||||||
to be incurred to completion and disposal. Provision is made for obsolete, slow moving or | ||||||
defective items where appropriate. | ||||||
Trade and other receivables | ||||||
Trade receivables are measured at initial recognition at fair value. Appropriate allowances for | ||||||
estimated irrecoverable amounts are recognised in the profit and loss account when there is | ||||||
objective evidence that the asset is impaired. When a trade receivable is considered uncollectible, | ||||||
it is written off against the allowance account. Subsequent recoveries of amounts previously written off | ||||||
are credited against the allowance account. Changes in the carrying amount of the allowance | ||||||
account are recognised in the income statement. | ||||||
Derivative financial instruments | ||||||
Forward contracts are used by the Group to manage its exposure to the risk associated with the variability | ||||||
in cash flows in relation to both recognised assets or liabilities and forecast transactions. All derivative | ||||||
financial instruments are measured at the balance sheet date at their fair value. | ||||||
Where derivative financial instruments are not designated as or not determined to be effective | ||||||
hedges, any gain or loss on the remeasurement of the fair value of the instrument at the | ||||||
balance sheet date is taken to the income statement. | ||||||
At the inception of the hedge relationship, the Group documents the | ||||||
relationship between the hedging instrument and the hedged item, along with its risk | ||||||
management objectives and its strategy for undertaking various hedge transactions. | ||||||
Furthermore, at the inception of the hedge and on an ongoing basis, the Group documents | ||||||
whether the hedging instrument that is used in a hedging relationship is effective in | ||||||
offsetting changes in cash flows of the hedged item. | ||||||
Changes in the fair value of derivatives that are designated and qualify as fair value hedges | ||||||
are recorded in the profit and loss immediately, together with any changes in the | ||||||
fair value of the hedged item that is attributable to the hedged risk. | ||||||
The effective portion of changes in the fair value of derivatives that are designated and qualify as | ||||||
cash flow hedges are deferred in equity. The gain or loss relating to the ineffective portion | ||||||
is recognised immediately in profit or loss and is included in the "other gains and losses" line of the | ||||||
income statement. Amounts deferred in equity are recycled in profit or loss in the periods | ||||||
when the hedged item is recognised in profit or loss. | ||||||
Hedge accounting is discontinued when the Group revokes the hedging relationship, the hedging | ||||||
instrument expires or is sold, terminated or exercised, or no longer qualifies for hedge accounting. | ||||||
The adjustment to the carrying amount of the hedged item arising from the hedged risk is amortised | ||||||
to the profit and loss from that date and is included in the "other gains and losses" line of the | ||||||
income statement. Any cumulative gain or loss deferred in equity at that time | ||||||
remains in equity and is recognised when the forecast transaction | ||||||
is ultimately recognised in profit or loss. When a forecast transaction is no longer expected to occur, | ||||||
the cumulative gain or loss that was deferred in equity is recognised immediately in profit or loss. | ||||||
A derivative is presented as a non-current asset or non-current liability if the remaining maturity | ||||||
of the instrument is more than 12 months and is not expected to be realised or settled within | ||||||
12 months. Other derivatives are presented as current assets or liabilities. | ||||||
Taxation | ||||||
The tax expense represents the sum of the tax currently payable and deferred tax. | ||||||
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net | ||||||
profit as reported in the income statement because it excludes some items of income | ||||||
or expense that are taxable or deductible in other years and it further excludes items that are | ||||||
never taxable or deductible. The Group's liability for current tax is calculated using tax rates that | ||||||
have been enacted or substantively enacted by the balance sheet date. | ||||||
Deferred tax is the tax expected to be payable or recoverable on differences between the | ||||||
carrying amount of assets and liabilities in the financial information and the corresponding tax | ||||||
bases used in the calculation of the taxable profit, and is accounted for using the balance sheet | ||||||
liability method. Deferred tax liabilities are generally recognised for all taxable temporary | ||||||
differences and deferred tax assets are recognised to the extent that it is probable that taxable | ||||||
profits will be available against which deductible temporary differences can be utilised. Such | ||||||
assets and liabilities are not recognised if the temporary difference arises from the initial | ||||||
recognition of goodwill or from the initial recognition of other assets and liabilities in a transaction | ||||||
that affects neither the taxable profit nor the accounting profit. | ||||||
Deferred tax is calculated at the tax rates that are expected to apply in the period when the | ||||||
liability is settled or the asset is realised. | ||||||
The carrying amount of deferred tax assets is reviewed at each balance sheet date and reduced | ||||||
to the extent that it is no longer probable that sufficient taxable profits will be available to allow | ||||||
all or part of the asset to be recovered. Deferred tax is charged or credited in the income | ||||||
statement, except where it relates to items charged or credited directly to equity, in which | ||||||
case the deferred tax is also dealt with in equity. | ||||||
Pensions | ||||||
The Group operates a defined contribution pension scheme in the UK, which is | ||||||
open to all employees and directors of the company. | ||||||
The amount charged to the income statement in respect of pension costs is the contribution | ||||||
payable in the year. | ||||||
Any differences between contributions payable in the year, and contributions actually paid are | ||||||
shown either as accruals or prepayments in the balance sheet. | ||||||
The amount included in the income statement in the year in respect of the pension scheme was £815,000 | ||||||
(2007:£253,000). The amounts included in creditors at 30 June 2008 in relation to the defined contribution | ||||||
pension scheme is £65,000 (2007:£38,000) | ||||||
Leases | ||||||
Leases are classified as financial leases whenever the terms of the lease transfer substantially | ||||||
all the risks and rewards of ownership to the lessee. All other leases are classified as | ||||||
operating leases. | ||||||
Rentals payable under operating leases are charged to income on a straight-line basis over the | ||||||
term of the relevant lease. Benefits received and receivable under an operating lease are also | ||||||
spread on a straight-line basis over the lease term. | ||||||
Assets held under finance leases are recognised as assets of the Group at their fair value or, if lower, | ||||||
at the present value of the the minimum lease payments, each determined at the inception of the lease. | ||||||
The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation. Lease | ||||||
payments are apportioned between finance charges and reduction of the lease obligation so as to achieve | ||||||
a constant rate of interest on the remaining balance of the liability. Finance charges are charged directly | ||||||
against income. | ||||||
Foreign exchange | ||||||
The individual financial information of each group company are presented in the currency of | ||||||
the primary economic environment in which it operates (its functional currency). For the | ||||||
purposes of the consolidated financial information, the results and financial position of each | ||||||
group company are expressed in pounds sterling which is the functional currency of the | ||||||
Company, and the presentation currency for the consolidated financial information. | ||||||
In preparing the financial information of the individual companies, transactions in currencies | ||||||
other than the entity's functional currency (foreign currencies) are recorded at the rates | ||||||
of exchange prevailing at the dates of the transactions. At each balance sheet date, monetary | ||||||
assets and liabilities that are denominated in foreign currencies are retranslated to the rates | ||||||
prevailing at the balance sheet date. Non-monetary items carried at fair value are translated at | ||||||
the rates prevailing at the date when the fair value was determined. Non-monetary items | ||||||
that are measured in terms of historical cost in a foreign currency are not retranslated. | ||||||
For the purpose of presenting consolidated financial information, the results | ||||||
of the operations of the Company's overseas subsidiaries, Abcam Inc and Abcam KK, are | ||||||
translated at the average rate of exchange during the period and their balance sheets at the | ||||||
rates ruling at the balance sheet date. Exchange differences arising on the translation of the | ||||||
opening net assets and results of operations are classified as equity and recognised in the | ||||||
Group's foreign currency translation reserve. | ||||||
The treatment of exchange differences on transactions entered into to hedge certain foreign | ||||||
currency risks is detailed under derivative financial instruments above. | ||||||
All other differences are included in the income statement in the period in which they arise. | ||||||
Share Based Payments | ||||||
The Group has applied the requirements of IFRS 2 Share-based payment. In accordance | ||||||
with the transitional provisions, IFRS 2 has been applied to all grants of equity instruments | ||||||
after 7 November 2002 that were unvested at 1 July 2006. | ||||||
The Group issues equity-settled share based payments to certain employees. Equity-settled | ||||||
share based payments are measured at the fair value (excluding the effect of non-market based | ||||||
vesting conditions) at the date of the grant. The fair value determined at the grant date of the | ||||||
equity-settled share based payments is expensed on a straight line basis over the vesting | ||||||
period, based on the Group's estimate of the number of shares that will eventually vest. There | ||||||
are both market and non-market based performance conditions attached to the vesting and | ||||||
exercising of equity instruments. Fair value is measured by the use of the Monte Carlo | ||||||
Simulation. The expected life used in the model has been adjusted, based on management's | ||||||
best estimate, for the effects of the non-transferability, exercise restrictions and behavioural | ||||||
considerations. Charges made to the income statement in respect of share-based payments | ||||||
are credited to retained earnings. | ||||||
Revenue recognition | ||||||
Revenue is measured at the fair value of the consideration received or receivable and represents | ||||||
amounts receivable for goods and services provided in the normal course of business, net of | ||||||
discounts, VAT and other sales related taxes. | ||||||
Sales of goods are recognised when goods are delivered and title has passed. | ||||||
Interest income is accrued on a time basis, by reference to the principal outstanding and the | ||||||
effective interest rate applicable. | ||||||
Dividend income from investments is recognised when the shareholders' rights to receive | ||||||
payment have been established. | ||||||
Cash and cash equivalents | ||||||
Cash and cash equivalents comprise cash on hand and demand deposits, and other short term | ||||||
highly liquid investments that are readily convertible to a known amount of cash and are subject | ||||||
to an insignificant risk of changes in value. | ||||||
Trade and other receivables | ||||||
Trade and other receiveables do not carry any interest and are stated at their nominal value as | ||||||
reduced by appropriate allowances for estimated irrecoverable amounts. | ||||||
Provisions | ||||||
Provisions are recognised when the Group has a present obligation as a result of a past event, | ||||||
and it is probable that the Group will be required to settle the obligation at the balance sheet | ||||||
date, and are discounted to present value where the effect is material. | ||||||
3.Critical accounting judgements and estimates | ||||||
In the application of the Group's accounting policies, which are described in note 2, the Directors | ||||||
are required to make estimates and assumptions, in accordance with IFRS, that affect the | ||||||
amounts reported as assets and liabilities as at the date of reporting the financial information, | ||||||
and the reported amounts of revenues and expenditure during the year. In preparation of the | ||||||
consolidated financial information, estimates and assumptions have been made by the Directors | ||||||
concerning the fair value of share options, the estimated useful lives of fixed assets, accruals | ||||||
and provisions required, the carrying value of investments, the recoverability of deferred tax | ||||||
assets, the carrying value of intangible assets and other similar evaluations. Actual amounts | ||||||
that result could differ from those estimates. | ||||||
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to | ||||||
accounting estimates are recognised in the period in which the estimate is revised if the revision | ||||||
affects only that period, or in the period of the revision and future periods if the revision affects | ||||||
both current and future periods. | ||||||
Key sources of estimation uncertaintly | ||||||
The key assumptions concerning the future and, and other key sources of estimation uncertainty at the | ||||||
balance sheet date, that have a risk of causing a material adjustment to the carrying amounts of assets and liabilities | ||||||
the most significant effect on the amounts recognised in financial information. | ||||||
Impairment of intangibles | ||||||
During the year,management renegotiated a product line agreement. Consequently, it was considered that | ||||||
the carrying value of the intangible was overstated and it was adjusted to take account of the | ||||||
anticipated future sales and the risk associated with the contract. | ||||||
Fair value of derivatives and other financial instruments | ||||||
As described in Note 26, the directors use their judgement in selecting an appropriate valuation technique for financial | ||||||
instruments not quoted in an active market. Valuation techniques commonly used by market practioners | ||||||
are applied. For derivative financial instruments, assumptions are made based on quoted market rates adjusted for | ||||||
specific features of the instrument. Other financial instruments are valued using a discounted cash flow analysis based | ||||||
on assumptions supported, where possible, by observable market prices or rates. | ||||||
Valuation of own manufactured inventory | ||||||
The standard costs used for the valuation of own manufactured inventory requires a number of assumptions concerning | ||||||
the allocation overheads. These assumptions are based primarily on managements estimates of time spent in | ||||||
each relevant area of activity. | ||||||
Provision for obsolete stock | ||||||
The provision for obsolete stock is based on managements estimation of the commercial life of inventory lines and | ||||||
is applied on a prudent basis. In assessing this, management takes in to consideration the sales history | ||||||
of products and the length of time that they have been available for resale. | ||||||
4.Income statement for the Company | ||||||||
The profit for the financial year dealt with in the financial information of the Company was £5,126,000 | ||||||||
(2007:£3,687,000). | ||||||||
5.Business and geographical segments | ||||||||
Geographical segments | ||||||||
The Group's operations are located in the UK, USA and Japan. | ||||||||
Business segments | ||||||||
The Directors consider that there are no identifiable business segments that are engaged in | ||||||||
providing individual products or services or a group of related products and services that are | ||||||||
subject to risks and returns that are different to the core business. | ||||||||
North | Europe | UK and | Japan | Total | ||||
America | rest of world | |||||||
Year ended | Year ended | Year ended | Year ended | Year ended | ||||
30 Jun 2008 | 30 Jun 2008 | 30 Jun 2008 | 30 Jun 2008 | 30 Jun 2008 | ||||
£000 | £000 | £000 | £000 | £000 | ||||
Revenue | ||||||||
External sales | 16,947 | 10,748 | 6,884 | 2,115 | 36,694 | |||
Total revenue | 16,947 | 10,748 | 6,884 | 2,115 | 36,694 | |||
Result | ||||||||
Segment result | 1,046 | 5,198 | 3,327 | 215 | 9,786 | |||
Unallocated corporate expenses | (2,415) | |||||||
Operating profit | 7,371 | |||||||
Investment revenues | 581 | |||||||
| ||||||||
Profit before tax | 7,952 | |||||||
Tax | (2,062) | |||||||
Profit after tax | 5,890 | |||||||
Other information | ||||||||
Capital additions | 28 | - | 2,744 | 4 | 2,776 | |||
Depreciation and amortisation | 172 | - | 1,255 | 10 | 1,437 | |||
Impairment losses recognised | ||||||||
in income | 642 | |||||||
Balance sheet | ||||||||
Assets | ||||||||
Segment assets | 2,946 | - | 25,384 | 727 | 29,057 | |||
Consolidated total assets | 29,057 | |||||||
Liabilities | ||||||||
Segment assets | (307) | - | (4,377) | (251) | (4,935) | |||
Consolidated total liabilities | (4,935) | |||||||
North | Europe | UK and | Japan | Total | ||||
America | rest of world | |||||||
Year ended | Year ended | Year ended | Year ended | Year ended | ||||
30 Jun 2007 | 30 Jun 2007 | 30 Jun 2007 | 30 Jun 2007 | 30 Jun 2007 | ||||
£000 | £000 | £000 | £000 | £000 | ||||
Revenue | ||||||||
External sales | 12,815 | 5,899 | 5,077 | 728 | 24,519 | |||
Total revenue | 12,815 | 5,899 | 5,077 | 728 | 24,519 | |||
Result | ||||||||
Segment result | 768 | 3,254 | 2,823 | (78) | 6,767 | |||
Unallocated corporate expenses | (1,729) | |||||||
Operating profit | 5,038 | |||||||
Investment revenues | 495 | |||||||
| ||||||||
Profit before tax | 5,533 | |||||||
Tax | (1,472) | |||||||
Profit after tax | 4,061 | |||||||
Other information | ||||||||
Capital additions | 285 | - | 3,848 | 31 | 4,164 | |||
Depreciation and amortisation | 117 | - | 673 | 5 | 795 | |||
Balance sheet | ||||||||
Assets | ||||||||
Segment assets | 2,133 | - | 20,131 | 565 | 22,829 | |||
Consolidated total assets | 22,829 | |||||||
Liabilities | ||||||||
Segment liabilities | (154) | - | (3,107) | (31) | (3,292) | |||
Consolidated total liabilities | (3,292) | |||||||
6.Profit for the year | |||||||
Profit for the year has been arrived at after charging (crediting): | |||||||
Year | Year | ||||||
ended | ended | ||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
£000 | £000 | ||||||
Net foreign exchange losses/(gains) | 136 | (283) | |||||
Operating lease rentals - land and buildings (note 9) | 545 | 237 | |||||
Depreciation and amortisation of owned assets | 1,437 | 795 | |||||
Impairment loss on Intangible assets | 642 | - | |||||
Cost of inventories recognised as an expense | 13,850 | 9,692 | |||||
Write-down of inventories recognised as an expense | 539 | 328 | |||||
Staff costs (note 8) | 7,308 | 5,250 | |||||
Impairment loss recognised on trade receivables | 367 | 153 | |||||
Legal fees associated with proposed sale of group | 250 | - | |||||
Auditors' remuneration (note 7) | 91 | 152 | |||||
7.Auditors' remuneration | |||||||
Year | Year | ||||||
ended | ended | ||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
£000 | £000 | ||||||
The analysis of the auditors' remuneration is as follows: | |||||||
Fees payable to the company's auditors for | |||||||
the audit of the company's annual accounts | 75 | 79 | |||||
Total audit fees | 75 | 79 | |||||
Fees payable to the company's auditors for | |||||||
other services to the group | |||||||
-Tax services | 13 | 73 | |||||
-Employment benefits | 3 | - | |||||
Total non-audit fees | 16 | 73 | |||||
8.Staff costs | |||||||
Group | |||||||
The average monthly number of employees (including executive directors) was: | |||||||
Year | Year | ||||||
ended | ended | ||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
Management, administrative, marketing and distribution | 130 | 101 | |||||
Laboratory | 36 | 20 | |||||
166 | 121 | ||||||
Their aggregate remuneration comprised: | |||||||
Year | Year | ||||||
ended | ended | ||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
£000 | £000 | ||||||
Wages and salaries | 5,776 | 4,369 | |||||
Social security costs | 525 | 466 | |||||
Pension costs | 815 | 253 | |||||
Charge in respect of share options granted | 192 | 162 | |||||
7,308 | 5,250 | ||||||
Company | |||||||
The average monthly number of employees (including executive directors) was: | |||||||
Year | Year | ||||||
ended | ended | ||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
Number | Number | ||||||
Management, administrative, marketing and distribution | 88 | 69 | |||||
Laboratory | 36 | 20 | |||||
124 | 89 | ||||||
Their aggregate remuneration comprised: | |||||||
Year | Year | ||||||
ended | ended | ||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
£000 | £000 | ||||||
Wages and salaries | 4,508 | 3,511 | |||||
Social security costs | 350 | 359 | |||||
Other pension costs | 776 | 233 | |||||
Charge in respect of share options granted | 162 | 162 | |||||
5,796 | 4,265 | ||||||
9.Operating lease arrangements | |||||||
Year | Year | ||||||
ended | ended | ||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
£000 | £000 | ||||||
Minimum lease payments under operating leases recognised as an expense | 545 | 237 | |||||
in the year | |||||||
At the balance sheet date, the Group had outstanding commitments for future minimum lease payments | |||||||
under non-cancellable operating leases, which fall due as follows: | |||||||
Group | 30 Jun 2008 | 30 Jun 2007 | |||||
£000 | £000 | ||||||
Within one year | 651 | 197 | |||||
In the second to fifth years inclusive | 1,615 | 631 | |||||
2,266 | 828 | ||||||
Company | 30 Jun 2008 | 30 Jun 2007 | |||||
£000 | £000 | ||||||
Within one year | 392 | 197 | |||||
In the second to fifth years inclusive | 996 | 631 | |||||
1,388 | 828 | ||||||
10.Other gains or losses | |||||||
Year | Year | ||||||
ended | ended | ||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
£000 | £000 | ||||||
Loss/(Gain) in fair value of forward exchange contracts | |||||||
-On contracts used as hedging instruments | - | (1) | |||||
-On other contracts | 197 | - | |||||
(see accounting policy note for derivative financial | |||||||
instruments.) | |||||||
11.Tax | |||||||
Year | Year | ||||||
ended | ended | ||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
£000 | £000 | ||||||
Current tax | 1,632 | 1,159 | |||||
Deferred tax (note 20) | 430 | 313 | |||||
2,062 | 1,472 | ||||||
Corporation tax is calculated at 29.5% (2007:30%) of the estimated assessable profit | |||||||
for the year. | |||||||
Taxation for other jurisdictions is calculated at the rates prevailing in the respective jurisdictions. | |||||||
The charge for the year can be reconciled to the profit per the income statement as follows: | |||||||
Year | Year | Year | Year | ||||
ended | ended | ended | ended | ||||
30 Jun 2008 | 30 Jun 2008 | 30 Jun 2007 | 30 Jun 2007 | ||||
£000 | % | £000 | % | ||||
Profit before tax | 7,952 |
| 5,533 |
| |||
Tax at the UK corporation tax rate | |||||||
of 29.5% (2007: 30%) | 2,346 | 29.50% | 1,660 | 30.00% | |||
Effect of different tax rates of subsidiaries | |||||||
operating in different jurisdictions | 158 | 1.99% | 110 | 1.99% | |||
Tax effect of expenses that are not deductible | |||||||
in determining taxable profit | 75 | 0.94% | 9 | 0.16% | |||
R&D Tax credit uplift | (325) | -4.09% | (199) | -3.60% | |||
Deduction for exercise for share options | (122) | -1.53% | (108) | -1.95% | |||
Prior year adjustments | (70) | -0.88% | - | - | |||
Tax expense and effective rate for the year | 2,062 | 25.93% | 1,472 | 26.60% | |||
12. Dividends | Year | Year | |||||
ended | ended | ||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
Amounts recognised as distributions to equity holders | £000 | £000 | |||||
in the year: | |||||||
Final dividend for the year ended 30 June 2007 | |||||||
of 3.19p (2006:2.00p) per share. | 1,116 | 691 | |||||
Interim dividend for the year ended 31 June 2008 | |||||||
of 1.04p (2007:0.80p) per share. | 365 | 277 | |||||
1,481 | 968 | ||||||
Proposed final dividend for the year ended | |||||||
30 June 2008 of 4.56p (2007:3.19 p) per share. | 1,599 | 1,105 | |||||
The proposed final dividend is subject to approval of the shareholders | |||||||
at the Annual General Meeting and has not been included as a liability | |||||||
in this financial information. | |||||||
13. Earnings per share | |||||||
The calculation of the basic and diluted earnings per share is based on the following data: | |||||||
Year | Year | ||||||
ended | ended | ||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
£000 | £000 | ||||||
Earnings | |||||||
Earnings for the purposes of basic and diluted earnings | 5,890 | 4,061 | |||||
per share being net profit attributable to | |||||||
equity holders of the parent. | |||||||
Number of shares | |||||||
Weighted average number of ordinary shares | |||||||
for the purposes of the basic earnings per share | 34,902,538 | 34,572,810 | |||||
Effect of dilutive potential ordinary shares: | |||||||
Share options | 671,614 | 943,674 | |||||
Weighted average number of ordinary shares for |
| ||||||
the purposes of diluted earnings per share. | 35,574,152 | 35,516,484 | |||||
Basic earnings per share is calculated by dividing the earnings attributable to ordinary | |||||||
shareholders by the weighted average number of shares outstanding during the year. | |||||||
Diluted earnings per share is calculated on the same basis as the basic earnings per share | |||||||
but with a further adjustment for the weighted average shares in issue to reflect the effect of all | |||||||
dilutive potential ordinary shares. The number of dilutive potential ordinary shares is derived from | |||||||
the number of share options granted to employees where the exercise price is less than the average | |||||||
market price of the Company's ordinary shares during the year. | |||||||
14.Intangible assets | |||||||
Group and Company | |||||||
Upfront | Distribution | Total | |||||
licence fees | Rights | ||||||
£000 | £000 | £000 | |||||
Cost | |||||||
At 1 July 2007 | 150 | 1,798 | 1,948 | ||||
Additions | 15 | 237 | 252 | ||||
Disposals | (1) | - | (1) | ||||
Revaluation for impairment | - | (642) | (642) | ||||
At 30 June 2008 | 164 | 1,393 | 1,557 | ||||
Amortisation | |||||||
At 1 July 2007 | 68 | 189 | 257 | ||||
Charge for the year | 53 | 254 | 307 | ||||
Disposals | (1) | - | (1) | ||||
At 30 June 2008 | 120 | 443 | 563 | ||||
Carrying amount | |||||||
At 30 June 2007 | 82 | 1,609 | 1,691 | ||||
At 30 June 2008 | 44 | 950 | 994 | ||||
The amortisation period for the upfront licence fees is 3 years. | |||||||
The amortisation period for the distribution rights is the term of the deal. | |||||||
The impairment loss is in respect of the reduction in the forecast revenues and profits of one of | |||||||
the distribution right agreement. | |||||||
15. Property, plant and equipment | |||||||
Group | |||||||
Computer | Laboratory | Office | Hybridomas | Total | |||
equipment | equipment | equipment | |||||
fixtures & | |||||||
fittings | |||||||
£000 | £000 | £000 | £000 | £000 | |||
Cost | |||||||
At 1 July 2007 | 454 | 2,531 | 948 | - | 3,933 | ||
Additions | 158 | 2,168 | 166 | 22 | 2,514 | ||
Exchange differences | 4 | 1 | 2 | - | 7 | ||
Disposals | (28) | (21) | (5) | - | (54) | ||
At 30 June 2008 | 588 | 4,679 | 1,111 | 22 | 6,400 | ||
Accumulated depreciation | |||||||
At 1 July 2007 | 218 | 346 | 537 | - | 1,101 | ||
Charge for the year | 149 | 709 | 269 | 3 | 1,130 | ||
Exchange differences | (23) | (9) | (5) | - | (37) | ||
Eliminated on disposals | 1 | - | 1 | - | 2 | ||
At 30 June 2008 | 345 | 1,046 | 802 | 3 | 2,196 | ||
Carrying amount | |||||||
At 30 June 2007 | 236 | 2,185 | 411 | - | 2,832 | ||
At 30 June 2008 | 243 | 3,633 | 310 | 19 | 4,204 | ||
Company | |||||||
Computer | Laboratory | Office | Internally | Total | |||
equipment | equipment | equipment | generated | ||||
fixtures & | assets | ||||||
fittings | |||||||
£000 | £000 | £000 | £000 | £000 | |||
Cost | |||||||
At 1 July 2007 | 344 | 2,286 | 750 | - | 3,380 | ||
Additions | 143 | 2,161 | 156 | 22 | 2,482 | ||
Disposals | (26) | (20) | (2) | - | (48) | ||
At 30 June 2008 | 461 | 4,427 | 904 | 22 | 5,814 | ||
Accumulated depreciation | |||||||
At 1 July 2007 | 180 | 292 | 449 | - | 921 | ||
Charge for the year | 113 | 660 | 172 | 3 | 948 | ||
Eliminated on disposals | (21) | (9) | (1) | - | (31) | ||
At 30 June 2008 | 272 | 943 | 620 | 3 | 1,838 | ||
Carrying amount | |||||||
At 30 June 2007 | 164 | 1,994 | 301 | - | 2,459 | ||
At 30 June 2008 | 189 | 3,484 | 284 | 19 | 3,976 | ||
16. Investments | |||||||
The company's subsidiaries at 30 June 2008 are: | |||||||
Proportion | Proportion | ||||||
Country of | of shares | of voting | |||||
incorporation | held | power held | |||||
Abcam Inc | USA | 100% | 100% | ||||
Abcam KK | Japan | 100% | 100% | ||||
Camgene | UK | 100% | 100% | ||||
Abcam Inc and Abcam KK are involved in the sale and distribution of antibodies. | |||||||
Camgene is dormant. | |||||||
Analysis of changes in Investments | |||||||
£000's | |||||||
Cost | |||||||
At 1 July 2007 | 16 | ||||||
Additions | 29 | ||||||
At 30 June 2008 | 45 | ||||||
Investments are held at cost less provision for impairment. All additions represent share based payment | |||||||
charges for share options issued by the company to employees of the subsidiaries. | |||||||
17. Inventories | |||||||
Group | Company | Group | Company | ||||
30 Jun 2008 | 30 Jun 2008 | 30 Jun 2007 | 30 Jun 2007 | ||||
£000 | £000 | £000 | £000 | ||||
Goods for resale | 4,506 | 4,501 | 3,102 | 3,089 | |||
18. Financial assets | |||||||
Group | Company | Group | Company | ||||
30 Jun 2008 | 30 Jun 2008 | 30 Jun 2007 | 30 Jun 2007 | ||||
£000 | £000 | £000 | £000 | ||||
Trade and other receivables: | |||||||
Amounts receivable for the sale of goods | 4,288 | 2,470 | 3,539 | 1,905 | |||
Allowance for doubtful debts | (591) | (413) | (224) | (197) | |||
3,697 | 2,057 | 3,315 | 1,708 | ||||
Owed by subsidiary undertakings | - | 2,169 | - | 1,461 | |||
Other debtors | 499 | 292 | 543 | 979 | |||
Prepayments | 664 | 626 | 469 | 424 | |||
4,860 | 5,144 | 4,327 | 4,572 | ||||
The average credit period taken for sales is 34.4 days (2007:44.3 days). No interest is charged on the receivables. | |||||||
Trade receivables are provided for based on estimated irrecoverable amounts determined by reference to past | |||||||
default experience. The group and company have provided fully for all amounts over 120 days because historical experience | |||||||
is such that receivables that are past due 120 days are not generally recoverable. Trade receivables between | |||||||
30 days and 120 days are provided for based on estimated irrecoverable amounts from the sale of | |||||||
goods determined by reference to past default experience. | |||||||
Credit limits for each customer are reviewed on a monthly basis. There are no customers | |||||||
who represent more than 5% of the total balance of trade receivables. | |||||||
The analysis below show the balances included in debtors which are past due at the | |||||||
reporting date for which the group or company has not provided as there has not | |||||||
been a significant change in credit quality and the amounts are still considered | |||||||
recoverable. | |||||||
Ageing of past due but not impaired receivables | |||||||
Group | Company | Group | Company | ||||
30 Jun 2008 | 30 Jun 2008 | 30 Jun 2007 | 30 Jun 2007 | ||||
£000 | £000 | £000 | £000 | ||||
30-60 days | 242 | 111 | 297 | 144 | |||
60-90 | 48 | 48 | 231 | 121 | |||
>90 days | - | - | 331 | 181 | |||
Total | 290 | 159 | 859 | 446 | |||
During the year the Group has formalised and improved the credit control procedures. This has resulted in a | |||||||
noticeable improvement in the ageing of the debtors. | |||||||
Movement in the allowance for doubtful debts | |||||||
Group | Company | Group | Company | ||||
30 Jun 2008 | 30 Jun 2008 | 30 Jun 2007 | 30 Jun 2007 | ||||
£000 | £000 | £000 | £000 | ||||
Balance at the beginning of the year | 224 | 198 | 85 | 46 | |||
Impairment losses recognised | 367 | 215 | 139 | 152 | |||
Balance at the end of the year | 591 | 413 | 224 | 198 | |||
In determining the recoverability of a trade receivable the Group and Company consider any change in | |||||||
the credit quality of the receivable from the date credit was initially granted up to the | |||||||
reporting date. The concentration of credit risk is limited due to the customer base being large | |||||||
and unrelated. Accordingly the directors believe that there is no further credit provision | |||||||
required in excess of the allowance for doubtful debts. | |||||||
Included in the allowance for doubtful debts are individually impaired trade receivables | |||||||
with a balance of £289,000 (2007: £121,000) relating to companies in financial | |||||||
difficulties. | |||||||
The impairment recognised represents the difference between the carrying amount of these | |||||||
trade receivables and the present value of the expected litigation proceeds. | |||||||
Neither the Group or the Company hold collateral over these balances. | |||||||
Ageing of impaired receivables | |||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
£000 | £000 | ||||||
60-90 days | 38 | - | |||||
>90 days | 553 | 224 | |||||
Total | 591 | 224 | |||||
The directors consider that the carrying amount of trade and other receivables approximates | |||||||
their fair value. | |||||||
Cash and cash equivalents | |||||||
Group | Company | Group | Company | ||||
30 Jun 2008 | 30 Jun 2008 | 30 Jun 2007 | 30 Jun 2007 | ||||
£000 | £000 | £000 | £000 | ||||
Cash and cash equivalents | 14,493 | 12,938 | 10,709 | 10,055 | |||
Cash and cash equivalents comprise cash held by the group and short-term deposits with | |||||||
an original maturity of three months or less. The carrying amount of these assets | |||||||
approximates their fair value. | |||||||
19. Derivative financial instruments | |||||||
Group and Company | |||||||
Current | |||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
£000 | £000 | ||||||
Derivatives that are designated and | |||||||
effective as hedging instruments | |||||||
carried at fair value | |||||||
Forward exchange contracts | - | 168 | |||||
Derivatives carried at fair value through | |||||||
profit and loss (FVTPL) | |||||||
Forward exchange contracts | (197) | - | |||||
(197) | 168 | ||||||
On 22 April 2008, all hedging instruments were de-designated and the fair value | |||||||
adjustments on the outstanding forward exchange contracts were charged through the profit and loss. | |||||||
20. Deferred tax | |||||||
The following are the major deferred tax liabilities and assets recognised by the Group | |||||||
and movements thereon during the current and prior reporting period. | |||||||
Group | |||||||
Accelerated | Share based | Other timing | Total | ||||
tax | payment | differences | |||||
depreciation | |||||||
£000 | £000 | £000 | £000 | ||||
At 1 July 2006 | (152) | 317 | 40 | 205 | |||
Charge to income | (397) | 46 | 15 | (336) | |||
Charge to equity | - | (57) | - | (57) | |||
|
|
|
| ||||
At 30 June 2007 | (549) | 306 | 55 | (188) | |||
Charge to income | (332) | (224) | 126 | (430) | |||
Credit to equity | - | 540 | - | 540 | |||
|
|
|
| ||||
At 30 June 2008 | (881) | 622 | 181 | (78) | |||
Company | |||||||
Accelerated | Share based | Other timing | Total | ||||
tax | payment | differences | |||||
depreciation | |||||||
At 1 July 2006 | (152) | 317 | 40 | 205 | |||
Charge to income | (397) | 46 | 15 | (336) | |||
Charge to equity | - | (57) | - | (57) | |||
|
|
|
| ||||
At 30 June 2007 | (549) | 306 | 55 | (188) | |||
Charge to income | (338) | 54 | 54 | (230) | |||
Credit to equity | - | 240 | - | 240 | |||
|
|
|
| ||||
At 30 June 2008 | (887) | 600 | 109 | (178) | |||
At the balance sheet date, the aggregate amount of temporary differences associated with undistributable | |||||||
earnings of subsidiaries for which a deferred tax liability has not been recognised is £1,028,000 | |||||||
(2007: £595,000). No liability has been recognised in respect of these differences because the | |||||||
Group is in a position to control the timing of the reversal of temporary differences and it is probable | |||||||
that such differences will not reverse in the foreseeable future. | |||||||
21.Other financial liabilities | |||||||
Group | Company | Group | Company | ||||
30 Jun 2008 | 30 Jun 2008 | 30 Jun 2007 | 30 Jun 2007 | ||||
£000 | £000 | £000 | £000 | ||||
Trade and other payables | |||||||
Trade creditors and accruals | 3,638 | 3,221 | 2,474 | 2,309 | |||
Deferred creditor | 86 | 86 | 110 | 110 | |||
Corporation tax | 382 | 269 | 248 | 243 | |||
Other taxes and social security | 160 | 159 | 124 | 124 | |||
Other creditors | 189 | 157 | 337 | 321 | |||
4,455 | 3,892 | 3,293 | 3,107 | ||||
Trade creditors and accruals principally comprise amounts outstanding for trade purchases and | |||||||
ongoing costs. The average credit period taken for trade purchases is 17 days (2007: 32 days). | |||||||
At the end of the previous financial year, it was decided that supplies should be paid on a more | |||||||
frequent basis. | |||||||
Most suppliers do not charge interest for the first 60 days of the invoice. The Group has financial risk | |||||||
management policies in place to ensure that all payables are paid within the credit time frame. | |||||||
The deferred creditor represents the earn-out payable on sales of products under a distribution agreement | |||||||
(see note 14) .The portion payable in more than 12 months is included in non-current liabilities. | |||||||
(2008: £109,000 2007: £386,000) | |||||||
The directors consider that the carrying amount of the trade and other payables approximates to their | |||||||
fair value. | |||||||
22. Provisions | |||||||
Group | Company | Group | Company | ||||
30 Jun 2008 | 30 Jun 2008 | 30 Jun 2007 | 30 Jun 2007 | ||||
£000 | £000 | £000 | £000 | ||||
Amounts payable | |||||||
under the loyalty scheme | |||||||
Opening balance | 75 | 75 | 45 | 45 | |||
Awarded in year | 314 | 314 | 245 | 245 | |||
Expired in year | (184) | (184) | (133) | (133) | |||
Redeemed in year | (109) | (109) | (82) | (82) | |||
Closing balance | 96 | 96 | 75 | 75 | |||
This represents amounts awarded to customer under a loyalty scheme. | |||||||
23. Share Capital | |||||||
Group and Company | |||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
£000 | £000 | ||||||
Authorised: | |||||||
1,000,000 ordinary shares of 1p each | 1,000 | 1,000 | |||||
Issued and fully paid: | |||||||
35,066,781 (2007:34,623,384) ordinary shares of 1p each | 351 | 346 | |||||
The Company operates a number of share option schemes for certain employees of the Group. Details | |||||||
are provided in note 25. | |||||||
24. Share Premium | |||||||
Group and Company | |||||||
£000 | |||||||
Balance at 1 July 2006 | 10,573 | ||||||
Premium arising on issue of equity shares | 46 | ||||||
Balance at I July 2007 | 10,619 | ||||||
Premium arising on issue of equity shares | 252 | ||||||
Balance at 30 June 2008 | 10,871 | ||||||
There were no costs of issue. | |||||||
25.Share-based payments | |||||||
Equity-settled share option scheme | |||||||
The Company operates a number of share option schemes for certain employees of the Group. | |||||||
The share based compensation charge is made up from option awards from the EMI plan, Unapproved | |||||||
share option plan, the US employees share option plan and the SAYE plan. Option grants under | |||||||
each scheme have been aggregated. | |||||||
The vesting period is from 1 - 3 years other than for those options with performance criteria, which vest | |||||||
when the criteria are met. If the options remain unexercised after a period of ten years from the date of | |||||||
grant the options expire. Options are forfeited if the employee leaves the Group before the options vest. | |||||||
The fair value of the options at the date of grant is the market price. | |||||||
The volatility of the options is based on the long term average volatility in the share price of five quoted | |||||||
companies that are considered to have a reasonable comparability with Abcam plc. | |||||||
The dividend yield is based on Abcam's actual dividend yield in the past. | |||||||
The risk free rate is the yield on UK Government Gilts at each date of grant. | |||||||
The employee exercise multiple is based on published statistics for a portfolio of companies. | |||||||
The employee exit rate is based on management's expectations and, in accordance with IFRS 2, is | |||||||
applied after vesting. | |||||||
Details of the share options outstanding during the year are as follows: | |||||||
Summary of all schemes | |||||||
Options outstanding as at 30 June 2008 had an exercise price of between 10p and 413p (2007:10p and 280p) | |||||||
The weighted average remaining contractual life is 8.12 years (2007:5.92 years). The weighted average | |||||||
fair value of the options outstanding at the end of the year was 65.24p (2007:46.27p) | |||||||
The Group recorded total expenses of £191,000 (2007: 162,000) | |||||||
2008 | 2007 | ||||||
No. of | Weighted | No. of | Weighted | ||||
Share options | average | Share options | average | ||||
exercise price | exercise price | ||||||
p | p | ||||||
Outstanding at beginning of year | 1,497,902 | 152.83 | 1,085,160 | 47.40 | |||
Granted during the year | 514,349 | 320.08 | 651,393 | 280.00 | |||
Forfeited during the year | (260,287) | 233.19 | (79,851) | 280.00 | |||
Exercised during the year | (441,815) | 57.37 | (158,800) | 30.00 | |||
Outstanding at the end of the year | 1,310,149 | 219.32 | 1,497,902 | 152.83 | |||
Exercisable at end of year | 302,640 | 43.07 | 657,960 | 20.00 | |||
Enterprise management incentive scheme | |||||||
2008 | 2007 | ||||||
No. of | Weighted | No. of | Weighted | ||||
Share options | average | Share options | average | ||||
exercise price | exercise price | ||||||
p | p | ||||||
Outstanding at beginning of year | 966,191 | 131.51 | 768,480 | 39.20 | |||
Granted during the year | 284,851 | 312.00 | 352,240 | 281.40 | |||
Forfeited during the year | (90,177) | 161.41 | (37,089) | 280.00 | |||
Exercised during the year | (327,337) | 53.80 | (117,440) | 31.80 | |||
Outstanding at the end of the year | 833,528 | 206.94 | 966,191 | 131.51 | |||
Exercisable at end of year | 262,640 | 40.11 | 547,040 | 28.00 | |||
The growth in the net assets of the Group means that Group will shortly exceed the limits set by the | |||||||
Inland Revenue for the tax incentives available under the Enterprise management incentice scheme. | |||||||
Unapproved share option scheme | 2008 | 2007 | |||||
No. of | Weighted | No. of | Weighted | ||||
Share options | average | Share options | average | ||||
exercise price | exercise price | ||||||
p | p | ||||||
Outstanding at beginning of year | 427,504 | 194.71 | 261,360 | 82.60 | |||
Granted during the year | 148,338 | 340.30 | 168,246 | 292.70 | |||
Forfeited during the year | (137,375) | 288.34 | (742) | 280.00 | |||
Exercised during the year | (83,558) | 71.76 | (1,360) | 62.50 | |||
Outstanding at the end of the year | 354,909 | 223.66 | 427,504 | 194.71 | |||
Exercisable at end of year | 40,000 | 62.50 | 80,000 | 0.00 | |||
Abcam Inc share scheme | 2008 | 2007 | |||||
No. of | Weighted | No. of | Weighted | ||||
Share options | average | Share options | average | ||||
exercise price | exercise price | ||||||
p | p | ||||||
Outstanding at beginning of year | 104,207 | 185.56 | 55,320 | 62.50 | |||
Granted during the year | 81,160 | 312.00 | 90,907 | 280.00 | |||
Forfeited during the year | (32,735) | 312.00 | (42,020) | 248.74 | |||
Exercised during the year | (30,920) | 56.33 | - | - | |||
Outstanding at the end of the year | 121,712 | 291.47 | 104,207 | 185.56 | |||
Exercisable at end of year | - | - | 30,920 | 0.00 | |||
During the year the company issued 1p ordinary shares as follows: | |||||||
Date issued | Number | Exercise | Total | ||||
of shares | Price | Paid | |||||
p | £ | ||||||
Oct-07 | 760 | 10.0 | 76 | ||||
Oct-07 | 20,640 | 25.0 | 5,160 | ||||
Oct-07 | 32,000 | 37.5 | 12,000 | ||||
Oct-07 | 235,080 | 62.5 | 146,933 | ||||
Nov-07 | 61,800 | 25.0 | 15,450 | ||||
Nov-07 | 20,000 | 30.0 | 6,000 | ||||
Dec-07 | 7,200 | 25.0 | 1,800 | ||||
Dec-07 | 2,120 | 62.5 | 1,325 | ||||
Feb-08 | 14,495 | 280.0 | 40,586 | ||||
Mar-08 | 10,000 | 25.0 | 2,500 | ||||
Mar-08 | 3,640 | 56.3 | 2,049 | ||||
Mar-08 | 4,040 | 62.5 | 2,525 | ||||
Apr-08 | 9,160 | 56.3 | 5,157 | ||||
Apr-08 | 2,760 | 62.5 | 1,725 | ||||
May-08 | 18,120 | 56.3 | 10,202 | ||||
May-08 | 1,582 | * | 224.0 | 3,544 | |||
443,397 | 257,032 | ||||||
*Issued under SAYE scheme. | |||||||
Fair value calculation: | |||||||
The fair value of the options schemes, other than those options with market based performance criteria, | |||||||
has been calculated using the Trinomial method. The inputs into the Trinomial model are as follows: | |||||||
EMI Scheme | |||||||
Grant date | 16.6.03 | 16.6.03 | 5.7.04 | 17.12.04 | 27.5.05 | 5.9.05 | |
Share price at grant -pence | 10 | 10 | 25 | 30 | 62.5 | 62.5 | |
Fair value at valuation date -pence | 2.6 | 2.6 | 8.5 | 12.3 | 19.2 | 19.1 | |
Exercise price -pence | 25 | 37.5 | 25 | 25 | 62.5 | 62.5 | |
Expected volatility | 40% | 40% | 35% | 35% | 30% | 30% | |
Expected life -years | 3 | 3.08 | 2 | 2.88 | 2 | 2 | |
Expected dividend yield | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | |
Risk free rate | 3.97% | 3.97% | 5.08% | 4.49% | 4.31% | 4.15% | |
Employee exercise multiple | 2 | 2 | 2 | 2 | 2 | 2 | |
Employee exit rate | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | |
Unapproved scheme | |||||||
Grant date | 20.12.04 | 20.12.04 | 30.9.05 | 30.9.05 | 27.10.05 | ||
Share price at grant -pence | 30 | 30 | 62.5 | 62.5 | 167 | ||
Fair value at valuation date -pence | 11.2 | 11.6 | 18.9 | 10.2 | 55.77 | ||
Exercise price -pence | 25 | 25 | 62.5 | 125 | 150 | ||
Expected volatility | 35% | 35% | 30% | 30% | 30% | ||
Expected life -years | 1.54 | 2 | 1.82 | 1.82 | 1.635 | ||
Expected dividend yield | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | ||
Risk free rate | 4.46% | 4.46% | 4.29% | 4.29% | 4.40% | ||
Employee exercise multiple | 2 | 2 | 2 | 2 | 2 | ||
Employee exit rate | 10.00% | 10.00% | 10.00% | 10.00% | 10.00% | ||
The fair value of options issued after September 2006, with market based performance criteria, are calculated | |||||||
using the Monte Carlo model. | |||||||
The inputs into the Monte Carlo model are as follows: | |||||||
Grant date | 7.9.06 | 8.11.07 | 7.5.08 | ||||
Share price at grant -pence | 280 | 312 | 413 | ||||
Fair value at valuation date -pence | 84 | 0.59 | 1.23 | ||||
Exercise price -pence | 280 | 312 | 413 | ||||
Expected volatility | 30% | 30% | 30% | ||||
Expected life -years | 3 | 3.01 | 3 | ||||
Expected dividend yield | 1.1 | 1.5 | 1.5 | ||||
Risk free rate | 4.57% | 4.80% | 4.79% | ||||
Employee exercise multiple | 2 | 2 | 2 | ||||
Employee exit rate | 9.53% | 12.00% | 12.00% | ||||
26. Financial Instruments | |||||||
Capital Risk Management | |||||||
The Group manages its capital to ensure that entities in the Group will be able to continue as | |||||||
going concerns whilst maximising the return to stakeholders through the optimisation of | |||||||
the debt and equity balance. The capital structure of the Group consists of cash and cash | |||||||
equivalents and equity attributable to the equity holders of the parent, comprising issued | |||||||
capital, reserves and retained earnings as disclosed in the Consolidated Statement of changes in | |||||||
Equity. | |||||||
Significant accounting policies | |||||||
Details of the significant accounting policies and methods adopted, including the criteria | |||||||
for recognition, the basis of measurement and the basis on which income and expenses | |||||||
are recognised, in respect of each class of financial asset, financial liability and | |||||||
equity instrument are disclosed in relevant note to the financial information. | |||||||
Categories of financial instruments | |||||||
All financial instruments are held for trading. | |||||||
Group | Company | ||||||
Carrying value | Carrying value | ||||||
30 Jun 2008 | 30 Jun 2007 | 30 Jun 2008 | 30 Jun 2007 | ||||
£000 | £000 | £000 | £000 | ||||
Financial assets | |||||||
Loans and receivables | |||||||
Amounts owed by Group undertakings | - | - | 2,033 | 1,461 | |||
Trade receivables | 3,697 | 3,315 | 2,057 | 1,708 | |||
VAT Recoverable | 234 | 440 | 234 | 440 | |||
(included in other debtors) | |||||||
3,931 | 3,755 | 4,324 | 3,609 | ||||
Cash and cash equivalents | |||||||
Deposits held to maturity | 12,587 | 8,500 | 11,520 | 8,500 | |||
Cash and cash equivalents | 1,906 | 2,209 | 1,418 | 1,555 | |||
14,493 | 10,709 | 12,938 | 10,055 | ||||
Financial liabilities | |||||||
Other financial liabilities at amortised cost | |||||||
Amounts owed by Group undertakings | - | - | 93 | - | |||
Trade payables | 1,994 | 1,719 | 1,784 | 1,324 | |||
Corporation tax payable | 382 | 248 | 269 | 564 | |||
Other taxes and social security | 160 | 124 | 160 | 124 | |||
Accruals | 2,014 | 1,277 | 1,680 | 1,170 | |||
Deferred creditor | 110 | 386 | 110 | 386 | |||
(shown under Non-Current liabilities) | |||||||
4,660 | 3,754 | 4,096 | 3,568 | ||||
The Directors consider there to be no material difference between the book value and the fair value of the | |||||||
Group's financial assets and liabilities.This is because most of the financial assets and liabilities are | |||||||
short term. | |||||||
Risk in relation to the use of financial instruments | |||||||
Credit risk | |||||||
Credit risk refers to the risk that a counterparty will default on its contractual obligations resulting in | |||||||
financial loss to the Group or the Company. | |||||||
Trade receivables consist of a large number of customers spread across diverse geographical areas. | |||||||
The Group does not have any significant credit risk exposure to any single counterparty. Ongoing | |||||||
credit evaluation is performed on the financial condition of accounts receivable and consideration. | |||||||
is given as to whether there is any impairment in the value of any amounts owing. | |||||||
The standard payment terms for receivables other than intra-group balances are 30 days. | |||||||
Any variation in these terms requires authorisation by senior management. Year end debtor days are 34.4 (2007:44.3). | |||||||
All overdue debts are provided for where collectability is considered doubtful or the value of the debt is impaired. | |||||||
Objective evidence of impairment could include the Group's past experience of collecting payments, an increase | |||||||
in the number of delayed payments in the portfolio past the average credit period of 34.4 days, as well as | |||||||
observable changes in international or local economic conditions. | |||||||
The standard payment terms for intragroup receivables is 45 days. There is not considered to be any risk of | |||||||
impairment of these receivables unless the financial assets of the entity holding the corresponding liability | |||||||
are impaired. | |||||||
The credit risk on liquid funds and derivative financial instruments is limited because the counterparties | |||||||
are banks with high credit-ratings assigned by international credit-rating agencies. Funds are split between | |||||||
at least two institutions. | |||||||
Market risk | |||||||
The Group's activities expose it primarily to the financial risks of changes in foreign currency | |||||||
exchange rates and interest rates. The Group enters into forward exchange contracts to hedge | |||||||
the exchange rate risk arising on the sales of goods and services denominated in Dollars and Euros. | |||||||
Foreign currency risk management | |||||||
The Group undertakes certain transactions denominated in foreign currencies. | |||||||
The Group's policy is to maintain natural hedges, where possible, by matching foreign currency | |||||||
revenue and expenditure. | |||||||
Exchange rate exposures are managed within approved policy parameters utilising forward | |||||||
exchange contracts. | |||||||
The carrying amounts of the Group's foreign currency denominated monetary assets and liabilities | |||||||
at the reporting date are as follows: | |||||||
Liabilities | Assets | ||||||
30 Jun 2008 | 30 Jun 2007 | 30 Jun 2008 | 30 Jun 2007 | ||||
£000 | £000 | £000 | £000 | ||||
Euros | 79 | 79 | 1,655 | 1,183 | |||
Dollars | 821 | 752 | 3,886 | 1,511 | |||
Yen | 17 | 32 | 539 | 455 | |||
917 | 863 | 6,080 | 3,149 | ||||
Foreign currency sensitivity analysis | |||||||
The Group's principal functional currency is pound sterling. The Group is mainly exposed to US dollars | |||||||
and Euros but has an increasing exposure to Japanese Yen. | |||||||
The following table details the Group's sensitivity to an 8% increase and decrease in Sterling against | |||||||
the relevant foreign currencies. 8% is considered by management to be a reasonably possible | |||||||
change in foreign exchange rates after giving consideration to changes in exchange rates over the last | |||||||
12 months. | |||||||
The sensitivity analysis includes only outstanding foreign currency | |||||||
denominated financial assets and liabilities and the cash flow hedging reserve and adjusts their translation | |||||||
at the period end for an 8% change in foreign exchange rates. The analysis below shows the increase or | |||||||
decrease in profit and the change in equity when the Sterling weakens or strengthens 8% against the relevant currency. | |||||||
Euro currency impact | Dollar currency impact | ||||||
2008 | 2007 | 2008 | 2007 | ||||
£000 | £000 | £000 | £000 | ||||
Impact of 8% strengthening | |||||||
- foreign currency financial assets | (117) | (82) | (227) | (56) | |||
and liabilities | |||||||
-Cash flow hedging reserve | - | 316 | - | 176 | |||
Impact of 8% weakening | |||||||
- foreign currency financial assets | 137 | 96 | 266 | 66 | |||
and liabilities | |||||||
-Cash flow hedging reserve | - | (396) | - | (562) | |||
The Group's sensitivity to foreign currency has increased during the period due to increased sales | |||||||
levels. This increase has been proportionately more than the increase in dollar purchases. | |||||||
In management's opinion, the sensitivity analysis is representative of the inherent foreign exchange risk | |||||||
at year end. | |||||||
The Group's policy is to maintain natural hedges, where possible, by matching | |||||||
USD revenue with USD expenditure. | |||||||
Forward exchange contracts | |||||||
It is the policy of the Group to enter into forward exchange contracts to manage the risk associated | |||||||
with anticipated sales transactions within 30% to 80% of the exposure generated. | |||||||
The Group uses a rolling hedging strategy with contracts with terms up to 12 months. Upon | |||||||
maturity of a forward contract, the Group may enter in to a new contract designated as a separate | |||||||
hedging relationship. | |||||||
Foreign currency forward contracts are measured using quoted forward exchange rates matching | |||||||
maturities of the contracts. | |||||||
Average | Foreign | Contract | Fair | ||||
Outstanding contracts | rate | currency | value | value | |||
30 Jun 2008 | 30 Jun 2008 | 30 Jun 2008 | 30 Jun 2008 | ||||
£000's | £000's | £000's | |||||
Sell US Dollars | |||||||
Less than 3 months | 1.97 | $1,200 | 608 | 3 | |||
3 to 6 months | 1.96 | $2,400 | 1,222 | 2 | |||
7 to 12 months | 1.94 | $600 | 309 | 2 | |||
1.96 | $4,200 | 2,139 | 7 | ||||
Sell Euros | |||||||
Less than 3 months | 1.33 | € 1,700 | 1,278 | (70) | |||
3 to 6 months | 1.34 | € 2,800 | 2,088 | (133) | |||
7 to 12 months | - | - | - | - | |||
1.34 | € 4,500 | 3,366 | (203) | ||||
Total of outstanding forward contracts | 5,505 | (196) | |||||
30 Jun 2007 | 30 Jun 2007 | 30 Jun 2007 | 30 Jun 2007 | ||||
£000's | £000's | £000's | |||||
Sell US Dollars | |||||||
Less than 3 months | 1.92 | $1,200 | 624 | 25 | |||
3 to 6 months | 1.92 | $2,250 | 1,171 | 46 | |||
7 to 12 months | 1.76 | $3,950 | 2,245 | 85 | |||
1.83 | $7,400 | 4,040 | 156 | ||||
Sell Euros | |||||||
Less than 3 months | 1.48 | € 400 | 268 | - | |||
3 to 6 months | 1.47 | € 3,950 | 2,685 | 4 | |||
7 to 12 months | 1.46 | € 2,100 | 1,441 | 8 | |||
1.47 | € 6,450 | 4,394 | 13 | ||||
Total of outstanding forward contracts | 8,434 | 169 | |||||
The analysis below shows the increase or decrease in profit and the change in equity when the | |||||||
Sterling weakens or strengthens 8% against the relevant currency. | |||||||
2008 | 2007 | ||||||
£000's | £000's | ||||||
Fair value of outstanding contracts should sterling | |||||||
strengthen by 8% | |||||||
US Dollars | 154 | 176 | |||||
Euros | 440 | 316 | |||||
594 | 492 | ||||||
2008 | 2007 | ||||||
£000's | £000's | ||||||
Fair value of outstanding contracts should sterling | |||||||
weaken by 8% | |||||||
US Dollars | (196) | (562) | |||||
Euros | (72) | (396) | |||||
(268) | (958) | ||||||
At 30 June 2007, all of the contracts were held as cash flow hedges. | |||||||
At 30 June 2008, none of the contracts were held as cash flow hedges. | |||||||
Liquidity risk management | |||||||
Ultimate responsibility for liquidity risk management rest with the board of directors, which has built | |||||||
an appropriate liquidity risk management framework for the management of the Group's short, medium | |||||||
and long-term funding and liquidity management requirements. The Group manages liquidity risk by | |||||||
maintaining adequate reserves and banking facilities by continuously monitoring cash flows and | |||||||
matching the maturity profiles of financial assets and liabilities. | |||||||
The Group and Company hold cash deposits at call or with a maturity of up to 12 months. | |||||||
At 30 June 2008, the average maturity of balances was 35 days of fixed rate deposits not | |||||||
sensitive to changes in interest rates. | |||||||
All funds are readily available to the Company to meet operational requirements. | |||||||
The amount owing from subsidiaries is payable on demand and is classified as being payable within 1 | |||||||
month. | |||||||
Trade payables are normally payable within 30 days of invoice. | |||||||
Liquidity and interest risk tables -financial liabilities | |||||||
(All balances are capital and do not include accrued interest) | |||||||
Weighted | |||||||
average | On demand | 1 to 3 | 3 months | Total | |||
interest | 1 month | months | to 1 year | ||||
rate | |||||||
% | £000's | £000's | £000's | £000's | |||
Group | |||||||
2008 | |||||||
Trade payables | - | 1,110 | 603 | 4 | 1,717 | ||
Accruals | - | 1,561 | - | 474 | 2,035 | ||
2,671 | 603 | 478 | 3,752 | ||||
Company | |||||||
2008 | |||||||
Trade payables | - | 1,610 | 25 | - | 1,635 | ||
Accruals | - | 1,284 | - | 418 | 1,702 | ||
2,894 | 25 | 418 | 3,337 | ||||
Group | |||||||
2007 | |||||||
Trade payables | - | 1,184 | 225 | - | 1,409 | ||
Accruals | - | 988 | - | 262 | 1,250 | ||
2,172 | 225 | 262 | 2,659 | ||||
Company | |||||||
2007 | |||||||
Trade payables | - | 1,194 | 217 | - | 1,411 | ||
Accruals | - | 848 | - | 235 | 1,083 | ||
2,042 | 217 | 235 | 2,494 | ||||
Interest rate risk sensitivity analysis | |||||||
An increase in 1% in the average interest rate during the year would have resulted in an increase | |||||||
in interest received by the Group of £113,000 (2007:£111,000) and by the Company of £103,000 (2007:£111,000) | |||||||
A decrease in 1% in the average interest rate during the year would have resulted in an equal | |||||||
and opposite impact on interest received by the Group and the Company as described above. | |||||||
Fair value of financial instruments | |||||||
The fair values of the financial assets and liabilities are determined as follows: | |||||||
Foreign exchange contracts are measured using quoted forward exchange rates and the yield curves | |||||||
derived from quoted interest rates matching maturities of these contracts. | |||||||
The Directors consider there to be no material difference between the book value and the fair value of | |||||||
the Group's financial assets and liabilities at the balance sheet date. This is because most of the | |||||||
financial assets and liabilities are short term. | |||||||
27.Related party transactions | |||||||
Under a New Product Development agreement with a laboratory associated with Tony Kouzarides, | |||||||
(a non-executive director of the company) Abcam provided products from its catalogue free of charge, with | |||||||
a resale value of £16,714 (2007:£14,000) and paid £36,148 in royalties (2007:£23,000).£6,632 of these | |||||||
royalties were outstanding at year end (2007:£7,000). | |||||||
Eddie Powell, who retired as Finance Director on 20 November 2007 was subsequently | |||||||
employed as an independent contractor for which he was paid £15,322. | |||||||
Remuneration of key personnel | |||||||
The remuneration of the Directors, who are the key management personnel of the Group, is set out | |||||||
below in aggregate for each of the categories specified in IAS 24 "Related Party Disclosures". | |||||||
Group and Company | |||||||
2008 | 2007 | ||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
Short term employee benefits and fees | 1,221 | 843 | |||||
Share-based payment | 50 | 29 | |||||
1,271 | 872 | ||||||
28.Notes to the cash flow statement | |||||||
Group | |||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
000's | 000's | ||||||
Operating profit for the year | 7,371 | 5,038 | |||||
Adjustments for: | |||||||
Depreciation of property,plant and equipment | 1,092 | 561 | |||||
Impairment losses on intangible assets | 642 | - | |||||
Amortisation of intangible assets | 309 | 234 | |||||
Share based compensation charge | 232 | 163 | |||||
Operating cash flows before movements | 9,646 | 5,996 | |||||
in working capital | |||||||
Increase in inventories | (1,405) | (744) | |||||
Increase in receivables | (533) | (1,566) | |||||
Increase in payables | 772 | 1,045 | |||||
Decrease in derivative | |||||||
financial instruments | 365 | - | |||||
(Decrease)/Increase in hedging reserve | (168) | 168 | |||||
Cash generated by operations | 8,677 | 4,899 | |||||
Income taxes paid | (1,535) | (1,473) | |||||
NET CASH FROM OPERATING | 7,142 | 3,426 | |||||
ACTIVITIES | |||||||
Company | |||||||
30 Jun 2008 | 30 Jun 2007 | ||||||
000's | 000's | ||||||
Operating profit for the year | 6,113 | 4,343 | |||||
Adjustments for: | |||||||
Depreciation of property,plant and equipment | 917 | 439 | |||||
Impairment losses on intangible assets | 642 | - | |||||
Amortisation of intangible assets | 306 | 234 | |||||
Share based compensation charge | 192 | 163 | |||||
Operating cash flows before movements | 8,170 | 5,179 | |||||
in working capital | |||||||
Increase in inventories | (1,412) | (741) | |||||
Increase in receivables | (572) | (1,896) | |||||
Increase in payables | 503 | 1,031 | |||||
Decrease in derivative | |||||||
financial instruments | 365 | - | |||||
(Decrease)/increase in hedging reserve | (168) | 168 | |||||
Cash generated by operations | 6,886 | 3,741 | |||||
Income taxes paid | (1,028) | (1,005) | |||||
NET CASH FROM OPERATING | 5,858 | 2,736 | |||||
ACTIVITIES |
29.Reconciliation of movements in equity | ||||||||
Group | ||||||||
Share | Share | Translation | Share-based | Hedging | Deferred | Retained | Total | |
capital | premium | reserve | compensation | reserve | tax reserve | earnings | ||
reserve | ||||||||
1 | 2 | 3 | 4 | |||||
£000's | £000's | £000's | £000's | £000's | £000's | £000's | £000's | |
Balance as at 1 July 2006 | 345 | 10,573 | (8) | 89 | - | 286 | 4,190 | 15,475 |
Exchange differences on | - | - | (28) | - | - | - | - | (28) |
translating foreign operations | ||||||||
Share-based compensation | - | - | - | 162 | - | - | - | 162 |
Deferred tax on outstanding | - | - | - | - | - | (30) | - | (30) |
share options | ||||||||
Profit for the year | - | - | - | - | - | - | 4,061 | 4,061 |
Total income / expense for | - | - | (28) | 162 | - | (30) | 4,061 | 4,165 |
the year | ||||||||
Issue of share capital | 1 | 46 | - | - | - | - | - | 47 |
Movement on hedging | - | - | - | - | 168 | - | - | 168 |
reserve for the adoption of hedge accounting | ||||||||
Payment of dividends | - | - | - | - | - | - | (968) | (968) |
(note 12) | ||||||||
Balance as at 30 June 2007 | 346 | 10,619 | (36) | 251 | 168 | 256 | 7,283 | 18,887 |
Exchange differences on translating | ||||||||
foreign operations | - | - | 3 | - | - | - | - | 3 |
Share-based compensation | - | - | - | 232 | - | - | - | 232 |
Deferred tax on outstanding share options | - | - | - | - | - | 502 | - | 502 |
share options | ||||||||
Profit for the year | - | - | - | - | - | - | 5,890 | 5,890 |
Total income / expense for | - | - | 3 | 232 | - | 502 | 5,890 | 6,627 |
the year | ||||||||
Issue of share capital | 5 | 252 | - | - | - | - | - | 257 |
Utilisation of derivative | - | - | - | - | (168) | - | - | (168) |
instruments | ||||||||
Payment of dividends | - | - | - | - | - | - | (1,481) | (1,481) |
(note 12) | ||||||||
Balance as at 30 June 2008 | 351 | 10,871 | (33) | 483 | - | 758 | 11,692 | 24,122 |
1. Exchange differences on translation of overseas operations | ||||||||
2. IFRS 2 Charge for fair value of share options | ||||||||
3. Gains and losses recognised on cash flow hedges | ||||||||
4. Portion of deferred tax asset arising on outstanding share options and share options exercised | ||||||||
and not taken to profit and loss in accordance with IAS12. | ||||||||
Company | ||||||||
Share | Share | Share-based | Hedging | Deferred | Retained | Total | ||
capital | premium | compensation | reserve | tax reserve | earnings | |||
reserve | ||||||||
1 | 2 | 3 | ||||||
£000's | £000's | £000's | £000's | £000's | £000's | £000's | ||
Balance as at 1 July 2006 | 345 | 10,573 | 89 | - | 286 | 3,663 | 14,956 | |
Share-based compensation | - | - | 162 | - | - | - | 162 | |
Deferred tax on outstanding | - | - | - | - | (30) | - | (30) | |
share options | ||||||||
Profit for the year | - | - | - | - | - | 3,687 | 3,687 | |
Total income / expense for | - | - | 162 | - | (30) | 3,687 | 3,819 | |
the year | ||||||||
Issue of share capital | 1 | 46 | - | - | - | - | 47 | |
Movement on hedging | - | - | - | 168 | - | - | 168 | |
reserve for the adoption of hedge accounting | ||||||||
Payment of dividends | - | - | - | - | - | (968) | (968) | |
(note 12) | ||||||||
Receipt of dividends | - | - | - | - | - | 272 | 272 | |
Balance as at 30 June 2007 | 346 | 10,619 | 251 | 168 | 256 | 6,654 | 18,294 | |
Share-based compensation | - | - | 193 | - | - | - | 193 | |
Deferred tax on outstanding | - | - | - | - | 502 | - | 502 | |
share options | ||||||||
Profit for the year | - | - | - | - | - | 5,126 | 5,126 | |
Total income / expense for | - | - | 193 | - | 502 | 5,126 | 5,821 | |
the year | ||||||||
Issue of share capital | 5 | 252 | - | - | - | - | 257 | |
Utilisation of derivative | - | - | - | (168) | - | - | (168) | |
instruments | ||||||||
Payment of dividends | - | - | - | - | - | (1,481) | (1,481) | |
(note 12) | ||||||||
Receipt of dividends | - | - | - | - | - | 403 | 403 | |
Balance as at 30 June 2008 | 351 | 10,871 | 444 | - | 758 | 10,702 | 23,126 | |
1. IFRS 2 Charge for fair value of share options | ||||||||
2. Gains and losses recognised on cash flow hedges | ||||||||
3. Portion of deferred tax asset arising on outstanding share options and share options exercised | ||||||||
and not taken to profit and loss in accordance with IAS12. |
Abcam plc | ||||
Notes to the consolidated financial information | ||||
For the year ended 30 June 2008 | ||||
30. Explanation of the transition to IFRS | ||||
This is the first year that the company has presented its financial information under IFRS. The | ||||
following disclosures are required in the year of transition. The last financial statements under | ||||
UK GAAP were for the year ended 30 June 2007 and the date of transition to IFRS was therefore | ||||
1 July 2006. | ||||
The principal impact of IFRS on this interim financial information has been in relation to | ||||
the following: | ||||
a. The scope of IAS 32 and IAS 39, Financial Instruments: Presentation | ||||
and Financial Instruments: Recognition and measurement respectively. | ||||
IAS 32 and IAS 39 require the company to recognise derivative financial instruments at their fair | ||||
value on the balance sheet (under UK GAAP, these were off balance sheet items).There may also | ||||
be a corresponding hedging reserve within equity on the balance sheet if hedge accounting | ||||
is applied. | ||||
The Group designates foreign exchange contracts as cash flow hedges and has implemented | ||||
hedge accounting. | ||||
b. The scope of IAS 12: Income taxes | ||||
Under IAS 12, a deferred tax asset arises on the unexercised share options issued to employees. | ||||
Under UK GAAP the tax charge is only recognised in the income statement when the tax becomes | ||||
payable. | ||||
Reconciliation of income statement for the year ended 30 June 2007 | ||||
Group | ||||
UK GAAP | IFRS adjustment | IFRS | ||
£000's | £000's | £000's | ||
Revenue | 24,519 | - | 24,519 | |
Cost of Sales | (10,020) | - | (10,020) | |
|
|
| ||
Gross Profit | 14,499 | - | 14,499 | |
Administration and management expenses | a | (7,422) | (168) | (7,590) |
excluding share based compensation charge |
| - | - | |
Share based compensation charge | (142) |
| (142) | |
Total management and administration expenses | (7,564) | (168) | (7,732) | |
Research and Development expenses | (1,709) | - | (1,709) | |
excluding share based compensation charge |
|
| - | |
Share based compensation charge | (20) | - | (20) | |
Total research and development expenses | (1,729) | - | (1,729) | |
|
|
| ||
OPERATING PROFIT | 5,206 | (168) | 5,038 | |
Investment revenue | 495 | - | 495 | |
|
|
| ||
PROFIT BEFORE TAXATION | 5,701 | (168) | 5,533 | |
Tax | b | (1,554) | 82 | (1,472) |
|
|
| ||
PROFIT FOR THE PERIOD FROM CONTINUING | 4,147 | (86) | 4,061 | |
OPERATIONS | ||||
Reconciliation of equity as at 1 July 2006 and 30 June 2007 | ||||
1 July 2006 | 30 June 2007 | |||
Total Equity under UK GAAP | 15,067 | 18,427 | ||
Loss/gains arising on derivatives | a | 118 | 204 | |
in a designated cash flow hedge | ||||
Loss/gains arising on deferred | b | 290 | 256 | |
tax on outstanding options | ||||
Total Equity under IFRS | 15,475 | 18,887 | ||
Reconciliation of balance sheet presentation at 1 July 2006 | ||||
Group | ||||
UK GAAP | IFRS adjustment | IFRS | ||
£000's | £000's | £000's | ||
NON-CURRENT ASSETS | ||||
Intangible assets | 77 | - | 77 | |
Property, plant and equipment | 1,094 | - | 1,094 | |
1,171 | - | 1,171 | ||
CURRENT ASSETS | ||||
Inventories | 2,358 | - | 2,358 | |
Trade and other receivables | 2,762 | - | 2,762 | |
Cash and cash equivalents | 11,884 | - | 11,884 | |
Derivative financial instruments | a | - | 169 | 169 |
17,004 | 169 | 17,173 | ||
CURRENT LIABILITIES | ||||
Trade and other payables | (2,461) | - | (2,461) | |
Current tax liabilities | a | (562) | (51) | (613) |
(3,023) | (51) | (3,074) | ||
NET CURRENT ASSETS | 13,981 | 118 | 14,099 | |
TOTAL ASSETS LESS CURRENT LIABILITIES | 15,152 | 118 | 15,270 | |
NON-CURRENT LIABILITIES | ||||
Deferred tax liabilities | b | (85) | 290 | 205 |
NET ASSETS | 15,067 | 408 | 15,475 | |
EQUITY | ||||
Share capital | 345 | - | 345 | |
Share premium account | 10,573 | - | 10,573 | |
Translation reserve | 89 | - | 89 | |
Share based compensation reserve | (8) | - | (8) | |
Retained earnings | a,b | 4,068 | 408 | 4,476 |
TOTAL EQUITY | 15,067 | 408 | 15,475 | |
Reconciliation of balance sheet presentation at 1 July 2006 | ||||
Company | ||||
UK GAAP | IFRS adjustment | IFRS | ||
£000's | £000's | £000's | ||
NON-CURRENT ASSETS | ||||
Intangible assets | 77 | - | 77 | |
Property, plant and equipment | 901 | - | 901 | |
Investments | 16 | 16 | ||
994 | - | 994 | ||
CURRENT ASSETS | ||||
Inventories | 2,348 | - | 2,348 | |
Trade and other receivables | 2,676 | - | 2,676 | |
Cash and cash equivalents | 11,312 | 11,312 | ||
Derivative financial instruments | a | - | 169 | 169 |
16,336 | 169 | 16,505 | ||
CURRENT LIABILITIES | ||||
Trade and other payables | (2,294) | - | (2,294) | |
Current tax liabilities | a | (411) | (51) | (462) |
(2,705) | (51) | (2,756) | ||
NET CURRENT ASSETS | 13,631 | 118 | 13,749 | |
TOTAL ASSETS LESS CURRENT LIABILITIES | 14,625 | 118 | 14,743 | |
NON-CURRENT LIABILITIES | ||||
Deferred tax liabilities | b | (77) | 290 | 213 |
NET ASSETS | 14,548 | 408 | 14,956 | |
EQUITY | ||||
Share capital | 345 | - | 345 | |
Share premium account | 10,573 | - | 10,573 | |
Share based compensation reserve | 89 | - | 89 | |
Retained earnings | a,b | 3,541 | 408 | 3,949 |
TOTAL EQUITY | 14,548 | 408 | 14,956 | |
Reconciliation of balance sheet presentation at 30 June 2007 | ||||
Group | ||||
UK GAAP | IFRS adjustment | IFRS | ||
£000's | £000's | £000's | ||
NON-CURRENT ASSETS | ||||
Intangible assets | 1,691 | - | 1,691 | |
Property, plant and equipment | 2,832 | - | 2,832 | |
4,523 | - | 4,523 | ||
CURRENT ASSETS | - | |||
Inventories | 3,102 | - | 3,102 | |
Trade and other receivables | 4,327 | - | 4,327 | |
Cash and cash equivalents | a | 10,709 | 10,709 | |
Derivative financial instruments | - | 168 | 168 | |
18,138 | 168 | 18,306 | ||
CURRENT LIABILITIES | ||||
Trade and other payables | (3,404) | 36 | (3,368) | |
(3,404) | 36 | (3,368) | ||
NET CURRENT ASSETS | 14,734 | 204 | 14,938 | |
TOTAL ASSETS LESS CURRENT LIABILITIES | 19,257 | 204 | 19,461 | |
NON-CURRENT LIABILITIES | ||||
Deferred creditor | (386) | - | (386) | |
Deferred tax liabilities | b | (444) | 256 | (188) |
NET ASSETS | 18,427 | 460 | 18,887 | |
EQUITY | ||||
Share capital | 346 | - | 346 | |
Share premium account | 10,619 | - | 10,619 | |
Translation reserve | (36) | - | (36) | |
Share based compensation reserve | 251 | - | 251 | |
Deferred tax reserve | b | - | 256 | 256 |
Hedging reserve | a | - | 168 | 168 |
Retained earnings | a | 7,247 | 36 | 7,283 |
TOTAL EQUITY | 18,427 | 460 | 18,887 | |
Reconciliation of balance sheet presentation at 30 June 2007 | ||||
Company | ||||
UK GAAP | IFRS adjustment | IFRS | ||
£000's | £000's | £000's | ||
NON-CURRENT ASSETS | ||||
Intangible assets | 1,691 | - | 1,691 | |
Property, plant and equipment | 2,459 | - | 2,459 | |
Investments | 16 | - | 16 | |
4,166 | - | 4,166 | ||
CURRENT ASSETS | ||||
Inventories | 3,089 | - | 3,089 | |
Trade and other receivables | 4,572 | - | 4,572 | |
Cash and cash equivalents | 10,055 | - | 10,055 | |
Derivative financial instruments | a | 168 | 168 | |
17,716 | 168 | 17,884 | ||
CURRENT LIABILITIES | ||||
Trade and other payables | (2,939) | - | (2,939) | |
Current tax liabilities | a | (279) | 36 | (243) |
(3,218) | 36 | (3,182) | ||
NET CURRENT ASSETS | 14,498 | 204 | 14,702 | |
TOTAL ASSETS LESS CURRENT LIABILITIES | 18,664 | 204 | 18,868 | |
NON-CURRENT LIABILITIES | ||||
Deferred creditor | (188) | - | (188) | |
Deferred tax liabilities | b | (642) | 256 | (386) |
NET ASSETS | 17,834 | 460 | 18,294 | |
EQUITY | ||||
Share capital | 346 | - | 346 | |
Share premium account | 10,619 | - | 10,619 | |
Share based compensation reserve | 251 | - | 251 | |
Deferred tax reserve | b | - | 256 | 256 |
Hedging reserve | a | - | 168 | 168 |
Retained earnings | a | 6,618 | 36 | 6,654 |
TOTAL EQUITY | 17,834 | 460 | 18,294 | |
Explanation of material adjustments to the cash flow statement for 2007 | ||||
Cash held under on short term deposits is included in cash and cash equivalents under IFRS. | ||||
Under previous GAAP, these amounts were excluded from the cash flow statement. | ||||
There are no other material differences between the cash flow statement statement | ||||
presented under IFRS and the cash flow statement presented under previous GAAP. |